Helena Laboratories, Corp. Cascade Abrazo aPTT Test Card - Product Usage: are to be used with the Cascade Abrazo analyzer and are intended for the determination of the activated Partial Thromboplastin Time (aPTT) of citrated whole blood or plasma, Model 5722, For Export Only. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Cascade Abrazo aPTT Test Card - Product Usage: are to be used with the Cascade Abrazo analyzer and are intended for the determination of the activated Partial Thromboplastin Time (aPTT) of citrated whole blood or plasma, Model 5722, For Export Only.
Brand
Helena Laboratories, Corp.
Lot Codes / Batch Numbers
Model Number: 5722 Lot Numbers: 1-20-5722 expiration date 90/30/2021, 3-20-5722 expiration date 11/30/2021, 4-20-5722 expiration date 12/31/2021
Products Sold
Model Number: 5722 Lot Numbers: 1-20-5722 expiration date 90/30/2021; 3-20-5722 expiration date 11/30/2021; 4-20-5722 expiration date 12/31/2021
Helena Laboratories, Corp. is recalling Cascade Abrazo aPTT Test Card - Product Usage: are to be used with the Cascade Abrazo analyzer and a due to Intermittent potential for shorter than expected clot times.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Intermittent potential for shorter than expected clot times.
Recommended Action
Per FDA guidance
On 01/05/2021, the firm sent an "URGENT MEDICAL DEVICE RECALL" Notification Letter via email to it distributors informing them that this Recall has been identified due to the potential for shorter than expected clot times on abnormal patients and on abnormal controls on some cards from specific lots and the use of these products may include difficulty achieving abnormal control results in range and incorrectly low patient results. Distributors were instructed to: 1) Immediately examine their inventory and quarantine the specific product lots 2) If they have further distributed the affected product, they are to identify these customers and notify them at once. In addition, the notification to their customers may be enhanced by including a copy of the recall notification letter, which must include instruction of what customers should do with the recalled product. 3) Complete and return enclosed response form as soon as possible Any questions, email or contact Dr. Jessica Jones Hanka at jhanka@helena.com or 1-800-231-5663 ext. 1177. Distributors were contacted by email and requested to evaluate inventory while the Recalling Firm investigated issue . Distributors were formally notified of recall on 1/5/2021 and provided with a template for a notification letter to translate and send to end users in each country. End users will be asked to return unused product to the distributor, and distributors will forward all returned product to Helena Labs. Distributors will be asked to provide an account of all product distributed. Effectiveness will be determined by evaluating the total product returned and the total product accounted for based on information provided by distributors.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026